Lucky James L 4

Accession 0001181431-13-015244

CIK 0001323885other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 12:11 PM ET

Size

20.5 KB

Accession

0001181431-13-015244

Insider Transaction Report

Form 4

Period: 2013-03-05

AtriCure, Inc.ATRC

Lucky James L

VP, Regulatory Affairs and QA

Transactions

Exercise/Conversion
Common Stock
2013-03-05$6.34/sh+13,949$88,437→ 60,342 total
Sale
Common Stock
2013-03-05$8.13/sh−13,949$113,405→ 46,393 total
Exercise/Conversion
Common Stock
2013-03-05$5.60/sh+31,500$176,400→ 77,893 total
Sale
Common Stock
2013-03-05$8.13/sh−31,500$256,095→ 46,393 total
Exercise/Conversion
Common Stock
2013-03-05$1.52/sh+9,473$14,399→ 55,866 total
Sale
Common Stock
2013-03-06$8.22/sh−616$5,064→ 55,250 total
Sale
Common Stock
2013-03-06$8.22/sh−4,000$32,880→ 51,250 total
Exercise/Conversion
Stock Option (right to buy)
2013-03-05−13,949→ 156,051 total
Exercise: $6.34From: 2007-09-06Exp: 2016-09-06→ Common Stock (13,949 underlying)
Exercise/Conversion
Stock Option (right to buy)
2013-03-05−31,500→ 124,551 total
Exercise: $5.60From: 2011-02-17Exp: 2020-02-17→ Common Stock (31,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2013-03-05−9,473→ 115,078 total
Exercise: $1.52From: 2005-01-01Exp: 2014-01-01→ Common Stock (9,473 underlying)

Footnotes (5)

[F1]This transaction was executed in multiple trades at prices ranging from $8.00 to $8.33 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $8.21 to $8.24 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]These options were granted on September 6, 2006 and vest and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vest and is exercisable in equal monthly installments on the same day of the month over the following three years.
[F4]These options were granted on February 17, 2010 and vest and are exercisable as to 25% of the shares one year from the date of grant, and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years.
[F5]These options were granted on January 1, 2004 and are exercisable cumulatively at a rate of 25% per annum beginning one year from the date of grant date.

Documents

1 file

4
rrd373277.xmlPrimary
FORM 4

Issuer

AtriCure, Inc.

CIK 0001323885

→

Entity typeother

Related Parties

filerCIK 0001336089

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 12:11 PM ET
Size: 20.5 KB

View on SEC.gov